| 000 | 01793 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515164428.0 | ||
| 264 | 0 | _c20100119 | |
| 008 | 201001s 0 0 spa d | ||
| 022 | _a0025-7753 | ||
| 024 | 7 |
_a10.1016/j.medcli.2008.11.029 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMartínez Marín, Virginia | |
| 245 | 0 | 0 |
_a[Fulvestrant in heavily pretreated postmenopausal women with advanced breast cancer]. _h[electronic resource] |
| 260 |
_bMedicina clinica _cSep 2009 |
||
| 300 |
_a371-4 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Evaluation Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xadministration & dosage |
| 650 | 0 | 4 |
_aBreast _xpathology |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinoma, Ductal, Breast _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinoma, Lobular _xdrug therapy |
| 650 | 0 | 4 |
_aEstradiol _xadministration & dosage |
| 650 | 0 | 4 |
_aEstrogen Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aFulvestrant |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPostmenopause |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMuñoz Martín, Andrés J | |
| 700 | 1 | _aViñuela Benéitez, M Carmen | |
| 700 | 1 | _aGarcía Alfonso, Pilar | |
| 700 | 1 | _aAlonso Muñoz, Antonio | |
| 700 | 1 | _aPérez Manga, Gumersindo | |
| 773 | 0 |
_tMedicina clinica _gvol. 133 _gno. 10 _gp. 371-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.medcli.2008.11.029 _zAvailable from publisher's website |
| 999 |
_c18774660 _d18774660 |
||